Results 61 to 70 of about 64,981 (166)

scFv-based biologics in diabetes: from therapeutic potential to clinical prospects. [PDF]

Front Immunol
Ge S, Wang L, Huang Y, Guo H, Wei F, Li P, Li S, Liu Q, Xu J, Xiao Y, Piress Dias AC, Ji L.   +11 more
europepmc   +1 more source

Applications of humanized mice in <i>Mycobacterium tuberculosis</i> infections (Review). [PDF]

Mol Med Rep
Han B, Liu F, Long J, Wang J, Cui Y, Yang H.   +5 more
europepmc   +1 more source

FDA Approval of Donanemab-azbt: A New Dawn in Alzheimer's Disease Treatment. [PDF]

Health Sci Rep
Riaz R, Fatima M, Ramzan S, Rathi D, Fatima F, Farooq M, Shaukat A, Khaliq N, Akilimali A.   +8 more
europepmc   +1 more source

Development and Validation of an ELISA to Detect Antibody to Onchocerca volvulus Infection Using Mammalian Expressed Recombinant Ov16. [PDF]

Am J Trop Med Hyg
Ossai S, Wang Y, Elder ES, Wickens K, Won KY, Secor WE, Handali S.   +6 more
europepmc   +1 more source

A Paradigm Shift in Snakebite Envenoming Therapy: From Conventional Antivenoms to Rationally Designed, Broadly Neutralizing Combination Therapies. [PDF]

ACS Pharmacol Transl Sci
Shi N, Wang J, Xu C, Jiang X, Ren C, Gao X, Luo L.   +6 more
europepmc   +1 more source

Engineering strategies and binding mechanisms of therapeutic anti-PD-1 antibodies approved by regulatory agencies globally. [PDF]

Front Immunol
Almagro JC, Gómez-Castellano K, Licona-Limón I, Carballo Uicab GJ, Ramírez-Villedas FD, Montes-Luna A, González-González E, Godínez-Palma S, Barrera Saldaña HA, Pérez-Tapia SM.   +9 more
europepmc   +1 more source

Transfer of trastuzumab and pertuzumab into human breast milk: a case report. [PDF]

Cancer Chemother Pharmacol
Buitelaar PLM, Pluim D, Hanssens S, Kerbage Y, Rosing H, Huitema ADR, Amant FC.   +6 more
europepmc   +1 more source

Development and Validation of Cell-Based Bioassay for the Detection of Neutralizing Antibodies to Ocrelizumab in Human Serum Using Antibody-Dependent Cell-Mediated Cytotoxicity Test in a Reporter Cell Line Expressing FcγRIIIa. [PDF]

Antibodies (Basel)
Strizhakova O, Poroshin G, Pershin A, Bakhareva Y, Shevchenko I, Lyagoskin I, Shukurov R, Khamitov R.   +7 more
europepmc   +1 more source

Antibody-drug conjugates in recurrent or metastatic HNSCC: relevant targets, clinical development, and future prospects. [PDF]

Front Immunol
Zhao H, Zhang S, Wang F, Yu P, Li J, Jia L, He P, Liu R, Zhang J, Wang K, Han R, Huangfu H.   +11 more
europepmc   +1 more source

Analytical similarity as the primary determinant of monoclonal antibody development: toward evidence-efficient regulatory frameworks. [PDF]

Front Drug Deliv
Niazi SK.
europepmc   +1 more source